Literature DB >> 24388161

Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.

Erwan Donal1, Lars H Lund2, Emmanuel Oger3, Camilla Hage2, Hans Persson4, Amélie Reynaud5, Pierre-Vladimir Ennezat6, Fabrice Bauer7, Catherine Sportouch-Dukhan8, Elodie Drouet8, Jean-Claude Daubert9, Cecilia Linde2.   

Abstract

BACKGROUND: Karolinska Rennes (KaRen) is a prospective observational study to characterize heart failure patients with preserved ejection fraction (HFpEF) and to identify prognostic factors for long-term mortality and morbidity. AIMS: To report characteristics and echocardiography at entry and after 4-8 weeks of follow-up.
METHODS: Patients were included following an acute heart failure presentation with B-type natriuretic peptide (BNP)>100 ng/L or N-terminal pro-BNP (NT-proBNP)>300 ng/L and left ventricular ejection fraction (LVEF)>45%.
RESULTS: The mean ± SD age of 539 included patients was 77 ± 9 years and 56% were women. Patient history included hypertension (78%), atrial tachyarrhythmia (44%), prior heart failure (40%) and anemia (37%), but left bundle branch block was rare (3.8%). Median NT-proBNP was 2448 ng/L (n=438), and median BNP 429 ng/L (n=101). Overall, 101 patients did not return for the follow-up visit, including 13 patients who died (2.4%). Apart from older age (80 ± 9 vs. 76 ± 9 years; P=0.006), there were no significant differences in baseline characteristics between patients who did and did not return for follow-up. Mean LVEF was lower at entry than follow-up (56% vs. 62%; P<0.001). At follow-up, mean E/e' was 12.9 ± 6.1, left atrial volume index 49.4±17.8mL/m(2). Mean global left ventricular longitudinal strain was -14.6 ± 3.9%; LV mass index was 126.6 ± 36.2g/m(2).
CONCLUSIONS: Patients in KaRen were old with slight female dominance and hypertension as the most prevalent etiological factor. LVEF was preserved, but with increased LV mass and depressed LV diastolic and longitudinal systolic functions. Few patients had signs of electrical dyssynchrony (ClinicalTrials.gov.- NCT00774709).
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Caractéristiques cliniques; Clinical characteristics; Echocardiographic characteristics; Heart failure with preserved ejection fraction; Insuffisance cardiaque à fraction d’éjection préservée; Registre; Registry; Échocardiographie

Mesh:

Substances:

Year:  2013        PMID: 24388161     DOI: 10.1016/j.acvd.2013.11.002

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  13 in total

Review 1.  Left ventricular strain and twisting in heart failure with preserved ejection fraction: an updated review.

Authors:  Marijana Tadic; Elisabeth Pieske-Kraigher; Cesare Cuspidi; Martin Genger; Daniel A Morris; Kun Zhang; Nina Alexandra Walther; Burket Pieske
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

2.  Association with left atrial volume index and long-term prognosis in patients without systolic dysfunction nor atrial fibrillation: an observational study.

Authors:  Yuta Seko; Takao Kato; Yusuke Morita; Yuhei Yamaji; Yoshizumi Haruna; Eisaku Nakane; Tetsuya Haruna; Moriaki Inoko
Journal:  Heart Vessels       Date:  2019-07-11       Impact factor: 2.037

3.  Aberrant static and dynamic functional network connectivity in heart failure with preserved ejection fraction.

Authors:  Liang Jiang; Shenghua Liu; Lin Li; Wen Wu; Zhongping Ai; Huiyou Chen; Xindao Yin; Yu-Chen Chen
Journal:  ESC Heart Fail       Date:  2022-05-13

4.  Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score.

Authors:  Olivier Huttin; Alan G Fraser; Lars H Lund; Erwan Donal; Cecilia Linde; Masatake Kobayashi; Tamas Erdei; Jean-Loup Machu; Kevin Duarte; Patrick Rossignol; Walter Paulus; Faiez Zannad; Nicolas Girerd
Journal:  ESC Heart Fail       Date:  2021-03-03

Review 5.  Heart failure and Alzheimer's disease.

Authors:  P Cermakova; M Eriksdotter; L H Lund; B Winblad; P Religa; D Religa
Journal:  J Intern Med       Date:  2014-08-01       Impact factor: 8.989

6.  Baseline characteristics of patients with heart failure and preserved ejection fraction at admission with acute heart failure in Saudi Arabia.

Authors:  Samah Abohammar; Mona Adel ElSaidy; Diaa Fathalla; Mubarak Aldosarri
Journal:  Egypt Heart J       Date:  2016-09-03

7.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

Review 8.  Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update.

Authors:  Daniele Masarone; Giuseppe Limongelli; Ernesto Ammendola; Marina Verrengia; Rita Gravino; Giuseppe Pacileo
Journal:  J Clin Med       Date:  2018-11-10       Impact factor: 4.241

9.  Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction.

Authors:  Ulrika Löfström; Camilla Hage; Gianluigi Savarese; Erwan Donal; Jean-Claude Daubert; Lars H Lund; Cecilia Linde
Journal:  ESC Heart Fail       Date:  2019-06-17

10.  Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study.

Authors:  Camilla Hage; Lars H Lund; Erwan Donal; Jean-Claude Daubert; Cecilia Linde; Linda Mellbin
Journal:  Open Heart       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.